The drug development bottlenecks of attrition and development time are bein
g addressed by acquiring a profile of the candidate's physicochemical and p
hysiological properties during early discovery phases. This information ass
ists selection and optimization of pharmaceutical properties in parallel wi
th activity. High throughput methods to measure the properties: solubility,
permeability, lipophilicity, pKa, stability and integrity are described an
d compared in this article. The underlying discovery requirements, needs an
d application strategies are discussed. (C) 2001 Wiley-Liss, Inc. and the A
merican Pharmaceutical Association.